Pancreatic cancer: silent killer
Pancreas cancer, a disease known as the King of Cancer, is of great concern because of its high virulence and low survival rate. In recent years, the incidence of pancreas cancer has been increasing globally, especially among older persons. Understanding the causes, symptoms, diagnosis and treatment of pancreas cancer is important for improving survival and quality of life.
Pancreas are an important organ in the human digestive system and are located behind the abdomen. Pancreas cancer occurs mainly in the head of the pancreas, about 75 per cent, and the rest in the end of the pancreas. Although early symptoms of pancreas cancer are not obvious, knowledge of their risk factors helps us in early prevention and diagnosis.
Smoking is one of the major risk factors for pancreatic cancer, which is two to three times higher among smokers than among non-smokers. In addition, high fat, high protein diets and obesity are also considered as potential causes of pancreas cancer. Diabetes and chronic pancreas are also at high risk.
Clinical symptoms and signs of pancreas cancer usually occur only in the middle and late stages of the disease. Abdominal pain and wasting are the most common symptoms, usually in the upper abdomen, which can be ejected to the back, with an increase in the roofing and a reduction in the contraction. Late-haired diabetes or an unknown acute pancreas outbreak may also be the first symptoms of pancreas cancer. Obstructive yellow blubber, i.e. yellowing of skin and eyes, is caused by tumours that oppress the chord. Delays in stomach emptiness and gypsies can lead to indigestion and vomiting.
Since early symptoms of pancreas cancer are not visible, most patients are in the middle and late stages of diagnosis, at a lower rate of surgical removal of about 20 per cent. Early diagnosis is therefore particularly important. The development of video technology has made it possible to diagnose small tumours and early tumours. Strengthening CT is an important means of judging the ectomization of tumours, while MRI and MRCP help to determine the extent and extent of choreography. The detection of the tumor marker CA19-9 is also one of the important methods used to diagnose pancreas cancer.
Surgery is the most important form of treatment for pancreas cancer and the only chance for long-term survival. Pancreatic cystectomy (PD) is the preferred root form of insulin cancer. In recent years, the application of improved insulin gestectomy has significantly increased the rate of surgical removal and reduced the incidence of post-operative complications. For patients who cannot be surgically removed, palliative care, such as choreography, combined gastrointestinal accolades, can alleviate symptoms such as yellow stings and stomach export barriers.
Post-operative combination therapy is an important means of extending life, including chemotherapy, immunotherapy and Chinese medicine. Gisitabin is the preferred drug for chemotherapy, and Trokai is the only drug approved by the FDA in the last decade to treat advanced pancreas cancer. Immunisation and Chinese medicine have also played an active role in the integrated treatment of pancreas cancer.
In cases of advanced pancreas cancer, treatment is aimed primarily at prolonging life, alleviating suffering and improving the quality of life. Local and whole-body treatments such as high-energy focus ultrasound (HIUF), free therapy and whole-body treatment, such as chemotherapy, can control progress to some extent. Post-operative follow-up and re-emergence treatment are also important components in improving survival rates.
In short, pancreas cancer is a disease with a high degree of malignity and a poor prognosis. Understanding their causes, symptoms, diagnostics and treatments will help us to prevent and diagnose early and to improve our survival and quality of life. In future research, we need to further explore more effective early diagnostic methods and treatments to defeat this silent killer.
